Boston, MA, United States of America

Annibale A Puca

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2004.


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,453 
Other
 patents

Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Annibale A Puca: Innovator in Genetic Research

Introduction

Annibale A Puca is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of genetics, particularly in understanding the factors that contribute to longevity and age-related diseases. His work has implications for health and wellness, especially as populations age.

Latest Patents

Annibale A Puca holds a patent titled "Genetic loci indicative of propensity for longevity and methods for identifying propensity for age-related disease." This invention relates to genetic loci and methods for using polymorphic markers indicative of the propensity for longevity and the resistance to age-related disease. In particular, the invention defines a specified region of human chromosome 4 associated with exceptional longevity. He has 1 patent to his name.

Career Highlights

Throughout his career, Puca has focused on the intersection of genetics and aging. His research has provided valuable insights into how genetic factors can influence lifespan and health in older age. His innovative approach has garnered attention in the scientific community.

Collaborations

Puca has collaborated with esteemed colleagues such as Louis M Kunkel and Thomas T Perls. These partnerships have enhanced the depth and reach of his research, contributing to advancements in the understanding of genetic markers related to longevity.

Conclusion

Annibale A Puca's work in genetic research highlights the importance of understanding the biological underpinnings of aging. His contributions pave the way for future innovations in health and longevity.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…